- Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective
-
Laspe I, Meier JJ, Nauck MA
- KMID: 2538938
- Diabetes Metab J.
- 2023 Jan;47(1):140-146.
- doi: 10.4093/dmj.2021.0322
In clinical practice, the distinction between type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) can be challenging, leaving patients with “ambiguous” diabetes type. Insulin-treated patients (n=115) previously... -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials
-
Kang YM, Cho YK, Lee J, Lee SE, Lee WJ, Park JY, Kim YJ, Jung CH, Nauck MA
- KMID: 2455665
- Diabetes Metab J.
- 2019 Aug;43(4):410-421.
- doi: 10.4093/dmj.2018.0070
BACKGROUND: Based on reported results of three large cardiovascular outcome trials (CVOTs) of glucagon-like peptide 1 receptor agonists (GLP-1 RAs), we aimed to investigate the overall effect of GLP-1 RAs... -
- CITED
-
- Close
- SHARE
-
- Close
